Neuromuscular Electrical Stimulation for Jaw-closing Dystonia

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

6 patients with jaw-closing dystonia will be treated with neuromuscular electrical stimulation over 8 weeks. The distance the mouth can be opened voluntarily and the oro-mandibular dystonia questionnaire (OMDQ-25) will be employed to determine whether there is any objective change in jaw opening or evidence of functional improvement.

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT04207632` - Quantifying Muscle Tone in Patients With Brain Injury - a Feasibility Study

NCT number	NCT03889704
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Terminated
Phase	N/A
Start date	May 16, 2019
Completion date	February 3, 2021

Neuromuscular Electrical Stimulation for Jaw-closing Dystonia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms